Identify the most promising targets leveraging our patient-derived single cell data foundation

Validate targets with robust experimental evidence applying our functional genomics capabilities, to ensure they are causally involved in the disease process

Shorten the path from hypothesis to actionable target with unbiased, data-driven recommendations

Strengthen confidence in preclinical safety and efficacy by identifying features linked to favorable pharmacodynamic characteristics

Identify molecular mechanisms that can enable patient stratification in the clinical setting

Develop a translational strategy that connects preclinical findings to clinical success

Identify patient subgroups likely to respond or tolerate treatment best

Build data-driven rationale for selecting indications, doses, or combinations

Better understand drug MoA and compare therapeutic performance to the current standard of care